drugset / Trial / NCT00518570
Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the clinical efficacy of Levetiracetam in the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in an open label study.
Timeline
- Start
- 2003-11
- Primary completion
- —
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1500 mg | — |